# Nurix Therapeutics, Inc.: Form 8-K, filed Oct 14, 2021

- Company: [Nurix Therapeutics, Inc.](/companies/nrix.md) (CIK 1549595)
- Form: 8-K
- Filed: 2021-10-14
- Accepted by EDGAR: Oct 14, 2021, 17:10 ET
- Period: 2021-10-14
- Accession: 0001564590-21-050869
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1549595/000156459021050869/nrix-8k_20211014.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1549595/000156459021050869/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1549595/000156459021050869/nrix-8k_20211014.htm

Filed Oct 14, 2021.
Source: SEC EDGAR, the filing index for accession 0001564590-21-050869. Last ingested by Listed: Nov 5, 2026, 13:59 ET. No prices; not investment advice.